Bank of America’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.5M Buy
2,841,155
+1,405,498
+98% +$12.6M ﹤0.01% 2013
2025
Q1
$10.8M Buy
1,435,657
+535,819
+60% +$4.02M ﹤0.01% 2612
2024
Q4
$6.77M Sell
899,838
-261,127
-22% -$1.96M ﹤0.01% 2796
2024
Q3
$8.82M Sell
1,160,965
-139,373
-11% -$1.06M ﹤0.01% 2722
2024
Q2
$8.04M Sell
1,300,338
-65,829
-5% -$407K ﹤0.01% 2729
2024
Q1
$6.94M Sell
1,366,167
-54,127
-4% -$275K ﹤0.01% 2820
2023
Q4
$8.51M Buy
1,420,294
+328,776
+30% +$1.97M ﹤0.01% 2566
2023
Q3
$7.73M Sell
1,091,518
-266,640
-20% -$1.89M ﹤0.01% 2515
2023
Q2
$9.56M Sell
1,358,158
-2,256,175
-62% -$15.9M ﹤0.01% 2336
2023
Q1
$30.1M Buy
3,614,333
+2,627,536
+266% +$21.9M ﹤0.01% 1547
2022
Q4
$11.3M Buy
986,797
+131,916
+15% +$1.51M ﹤0.01% 2183
2022
Q3
$10.8M Buy
854,881
+92,446
+12% +$1.16M ﹤0.01% 2152
2022
Q2
$8.07M Buy
762,435
+25,994
+4% +$275K ﹤0.01% 2490
2022
Q1
$12M Buy
736,441
+379,757
+106% +$6.17M ﹤0.01% 2331
2021
Q4
$4.94M Sell
356,684
-224,960
-39% -$3.12M ﹤0.01% 3127
2021
Q3
$8.36M Sell
581,644
-388,484
-40% -$5.58M ﹤0.01% 2625
2021
Q2
$15.3M Sell
970,128
-379,005
-28% -$5.99M ﹤0.01% 2101
2021
Q1
$13.7M Buy
1,349,133
+623,274
+86% +$6.34M ﹤0.01% 2139
2020
Q4
$5.41M Sell
725,859
-133,640
-16% -$995K ﹤0.01% 2652
2020
Q3
$2.95M Sell
859,499
-932,049
-52% -$3.2M ﹤0.01% 2969
2020
Q2
$8.54M Buy
1,791,548
+1,129,996
+171% +$5.38M ﹤0.01% 2105
2020
Q1
$1.32M Buy
661,552
+285,051
+76% +$570K ﹤0.01% 3382
2019
Q4
$1.3M Buy
376,501
+275,753
+274% +$951K ﹤0.01% 3697
2019
Q3
$288K Sell
100,748
-321,185
-76% -$918K ﹤0.01% 4674
2019
Q2
$1.6M Buy
421,933
+180,561
+75% +$684K ﹤0.01% 3620
2019
Q1
$1.97M Buy
241,372
+198,375
+461% +$1.61M ﹤0.01% 3451
2018
Q4
$347K Buy
42,997
+10,546
+32% +$85.1K ﹤0.01% 4476
2018
Q3
$248K Sell
32,451
-83,780
-72% -$640K ﹤0.01% 4666
2018
Q2
$666K Buy
116,231
+61,960
+114% +$355K ﹤0.01% 4076
2018
Q1
$259K Sell
54,271
-4,671
-8% -$22.3K ﹤0.01% 4537
2017
Q4
$289K Buy
58,942
+32,668
+124% +$160K ﹤0.01% 4493
2017
Q3
$138K Buy
26,274
+10,240
+64% +$53.8K ﹤0.01% 4776
2017
Q2
$89K Sell
16,034
-8,995
-36% -$49.9K ﹤0.01% 4900
2017
Q1
$210K Buy
25,029
+7,568
+43% +$63.5K ﹤0.01% 4579
2016
Q4
$111K Buy
17,461
+7,810
+81% +$49.6K ﹤0.01% 4814
2016
Q3
$42K Sell
9,651
-6,294
-39% -$27.4K ﹤0.01% 5032
2016
Q2
$45K Buy
15,945
+10,445
+190% +$29.5K ﹤0.01% 5066
2016
Q1
$16K Sell
5,500
-16,985
-76% -$49.4K ﹤0.01% 5391
2015
Q4
$232K Sell
22,485
-35,107
-61% -$362K ﹤0.01% 4372
2015
Q3
$657K Sell
57,592
-33,782
-37% -$385K ﹤0.01% 3753
2015
Q2
$1.36M Buy
91,374
+41,683
+84% +$622K ﹤0.01% 3066
2015
Q1
$448K Buy
49,691
+823
+2% +$7.42K ﹤0.01% 3538
2014
Q4
$595K Buy
48,868
+20,569
+73% +$250K ﹤0.01% 3470
2014
Q3
$277K Sell
28,299
-64,880
-70% -$635K ﹤0.01% 3855
2014
Q2
$1.19M Buy
93,179
+8,879
+11% +$113K ﹤0.01% 2944
2014
Q1
$892K Sell
84,300
-11,216
-12% -$119K ﹤0.01% 3130
2013
Q4
$726K Buy
95,516
+11,171
+13% +$84.9K ﹤0.01% 3376
2013
Q3
$614K Sell
84,345
-96,900
-53% -$705K ﹤0.01% 3348
2013
Q2
$281K Buy
+181,245
New +$281K ﹤0.01% 4134